AGAP2 and non-small cell lung carcinoma: Moreover, the relationship between AGAP2-AS1 expression and clinical features in NSCLC patients was analyzed; the results showed that increased AGAP2-AS1 levels were correlated with tumor size (P<0.01) and advanced pathological stage (P<0.01) in NSCLC patients.